InveniAI Corporation helping to facilitate drug discovery with its AI-driven technology

InveniAI Corporation CEO Krishnan Nandabalan sat down with Proactive at the 2019 BIO Investor Forum in San Francisco. 

Connecticut-based InveniAI provides AI-driven technology solutions to help facilitate drug discovery. The company works with biopharmas that are in post-stage one phases.

Related posts

Leave a comment

Your email address will not be published. Required fields are marked *

*